SCHEMBL19797381

SCHEMBL19797381

Cc1cc(P(=O)(c2ccccc2)c2cccnc2)ccc1N1c2ccccc2C(C)(C)c2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 3/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ KCNA5 P22460 4/20 0.33
▸ KCNN4 O15554 3/20 0.33
▸ EGLN1 Q9GZT9 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HDAC1 Q13547 4/20 0.32
▸ HDAC6 Q9UBN7 4/20 0.32
▸ HDAC3 O15379 1/20 0.32
▸ HDAC11 Q96DB2 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ CYP2A6 P11509 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19797383 0.91 ALDH1A1 (0.38) LMNAMAPTKMT2AHTTALDH1A1
SCHEMBL19797385 0.90 CYP19A1 (0.35) MAPTALDH1A1KCNA5EGLN1KDM4E
SCHEMBL19797386 0.89 CYP19A1 (0.36) EGLN1CYP2A6
SCHEMBL19797384 0.86 CYP2A6 (0.38) MAPTKCNA5KCNN4EGLN1HDAC1
SCHEMBL19797354 0.85 LMNA (0.40) LMNAMAPTKMT2AGAAHTT
SCHEMBL19797359 0.83 LMNA (0.40) LMNAMAPTKMT2AGAAHTT
SCHEMBL19797382 0.83 ALDH1A1 (0.31) ALDH1A1NPSR1
SCHEMBL19797376 0.83 NPSR1 (0.31) MAPTNPSR1EGLN1
SCHEMBL19797413 0.83 LMNA (0.38) LMNAMAPTKMT2AGAAHTT
SCHEMBL19797392 0.80 EGLN1 (0.41) EGLN1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10388889-B2 Substituted phosphines as components of organic light-emitting devices SAMSUNG DISPLAY CO., LTD. (KR) 2019-08-20 — — US disclosed
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-25 — — US disclosed
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CYP1A1, CYP1B1 LMNA 2798/4885MAPT 1528/4885KMT2A 1251/4885
US-10388889-B2 Substituted phosphines as components of organic light-emitting devices CRY1, CRY2, PER2 LMNA 3701/4885MAPT 2138/4885KMT2A 1002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback